These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18841554)

  • 1. [Reversible Parkinsonism and cognitive impairment following treatment with valproate].
    Toribio-Díaz ME; Morera-Guitart J; Palao-Duarte S
    Rev Neurol; 2008 Oct 1-15; 47(7):390-1. PubMed ID: 18841554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reversible parkinsonism induced by prolonged treatment with valproate].
    Barroso B
    Therapie; 2002; 57(4):410-1. PubMed ID: 12422564
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases.
    Masmoudi K; Gras-Champel V; Masson H; Andréjak M
    Pharmacopsychiatry; 2006 Jan; 39(1):9-12. PubMed ID: 16453247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drug.
    Hauben M; Reich L
    Mov Disord; 2005 Mar; 20(3):387. PubMed ID: 15641014
    [No Abstract]   [Full Text] [Related]  

  • 5. Valproate-induced parkinsonism, glial cells and Alexander's disease.
    Sechi GP; Conti M; Sau GF; Cocco GA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1351-2. PubMed ID: 18495313
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproate-induced Parkinsonism in epilepsy patients.
    Jamora D; Lim SH; Pan A; Tan L; Tan EK
    Mov Disord; 2007 Jan; 22(1):130-3. PubMed ID: 17115396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversible neuropsychological deterioration associated with valproate].
    Vaquerizo J; Gómez Martín H; González Iglesias E; Cardesa JJ
    Rev Neurol; 1995; 23(119):148-50. PubMed ID: 8548612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reversible dementia-like condition and parkinsonism in an elderly woman. Idiosyncratic adverse effects connected to 11 years of antiepileptic medication].
    Lindbom U; Taubert B; Fahlqvist MS; Bergens A; Kimland E; Jonsson EW; Bergman U
    Lakartidningen; 2009 Mar 18-24; 106(12):863-5. PubMed ID: 19452788
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible cognitive and neurological symptoms during valproic acid therapy.
    Hommet C; Mondon K; de Toffol B; Constans T
    J Am Geriatr Soc; 2007 Apr; 55(4):628. PubMed ID: 17397449
    [No Abstract]   [Full Text] [Related]  

  • 10. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.
    Ristić AJ; Vojvodić N; Janković S; Sindelić A; Sokić D
    Epilepsia; 2006 Dec; 47(12):2183-5. PubMed ID: 17201721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive impairment and parkinsonism due to use of sodium valproate].
    Schreur L; Middeljans-Tijssen CW; Hengstman GJ; Olde Rikkert MG
    Tijdschr Gerontol Geriatr; 2009 Feb; 40(1):29-33. PubMed ID: 19326700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Parkinsonism in older patients receiving sodium valproate.
    Macphee GJ; Stewart DA
    Mov Disord; 2007 Jun; 22(8):1211. PubMed ID: 17443705
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuropsychiatric symptoms caused by valproic acid].
    Andrade R; García-Espinosa A; Pérez-Montoto A; Toledo-Sotomayor G; Remón-González Y; Frades-García V
    Rev Neurol; 2010 Jan 1-15; 50(1):62-3. PubMed ID: 20073028
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible Valproic Acid-Induced Parkinsonism and Cognitive Impairment in an Elderly Patient With Bipolar Disorder I.
    Hassamal S; Waller S; Reese K; Testa C
    Turk Psikiyatri Derg; 2016; 27(3):213-217. PubMed ID: 27711942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stupor associated with the treatment of epilepsy with valproate].
    Skjødt T; Sørensen T
    Ugeskr Laeger; 1984 Apr; 146(15):1137-8. PubMed ID: 6429914
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cognitive impairment caused by valproate].
    Villosladaa P; Borrás C; Montalbán X
    Med Clin (Barc); 2000 Dec; 115(20):799. PubMed ID: 11171459
    [No Abstract]   [Full Text] [Related]  

  • 17. [Parkinsonism induced by sodium valproate].
    del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
    Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute akinetic crisis with marked cognitive impairment due to Valproate treatment.
    Reif A; Hamelbeck B; Pfuhlmann B
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):356-7. PubMed ID: 12673616
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of severe parkinsonism in an elderly person induced by valproic acid.
    Tada H; Ogihara T; Nakamura T; Sasayama D; Sugiyama N; Takahashi Y; Washizuka S; Amano N
    Psychogeriatrics; 2017 Jan; 17(1):76-77. PubMed ID: 26757408
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproate-induced rest tremor and parkinsonism.
    Baizabal-Carvallo JF; Alonso-Juarez M
    Acta Neurol Belg; 2021 Apr; 121(2):515-519. PubMed ID: 31721077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.